Monday, April 15, 2013

The Washington Post: Report: Compounding pharmacies go untracked


State authorities who are supposed to oversee the type of specialized pharmacy at the heart of last fall’s deadly meningitis outbreak lack the most basic information about the companies they are supposed to regulate, according to a congressional report to be released Monday.
State boards of pharmacy generally don’t know which pharmacies in their state engage in compounding, the custom mixing of medications for individual patients. Nor do they know how much medication they make, how much of it is sterile or whether any products are sold across state lines. Only two states, Mississippi and Missouri, routinely track the number of compounding pharmacies in their states.

Continue reading here

No comments: